Phase transition in early universe changes strength of interaction between dark and normal matter.
Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without dark matter, for example, the motion of galaxies cannot be explained. But it has never been possible to detect dark matter in an experiment.
Currently, there are many proposals for new experiments: They aim to detect dark matter directly via its scattering from the constituents of the atomic nuclei of a detection medium, i.e., protons and neutrons.
In the HYPER model, sometime after the formation of dark matter in the early universe, the strength of its interaction with normal matter increases abruptly—which on the one hand, makes it potentially detectable today and at the same time can explain the abundance of dark matter.
The new diversity in the dark matter sector
Since the search for heavy dark matter particles, or so-called WIMPS, has not yet led to success, the research community is looking for alternative dark matter particles, especially lighter ones. At the same time, one generically expects phase transitions in the dark sector—after all, there are several in the visible sector, the researchers say. But previous studies have tended to neglect them.
“There has not been a consistent dark matter model for the mass range that some planned experiments hope to access. “However, our HYPER model illustrates that a phase transition can actually help make the dark matter more easily detectable,” said Elor, a postdoctoral researcher in theoretical physics at JGU.
The challenge for a suitable model: If dark matter interacts too strongly with normal matter, its (precisely known) amount formed in the early universe would be too small, contradicting astrophysical observations. However, if it is produced in just the right amount, the interaction would conversely be too weak to detect dark matter in present-day experiments.
“Our central idea, which underlies the HYPER model, is that the interaction changes abruptly once—so we can have the best of both worlds: the right amount of dark matter and a large interaction so we might detect it,” McGehee said.
And this is how the researchers envision it: In particle physics, an interaction is usually mediated by a specific particle, a so-called mediator—and so is the interaction of dark matter with normal matter. Both the formation of dark matter and its detection function via this mediator, with the strength of the interaction depending on its mass: The larger the mass, the weaker the interaction.
The mediator must first be heavy enough so that the correct amount of dark matter is formed and later light enough so that dark matter is detectable at all. The solution: There was a phase transition after the formation of dark matter, during which the mass of the mediator suddenly decreased.
“Thus, on the one hand, the amount of dark matter is kept constant, and on the other hand, the interaction is boosted or strengthened in such a way that dark matter should be directly detectable,” Pierce said.
New model covers almost the full parameter range of planned experiments
“The HYPER model of dark matter is able to cover almost the entire range that the new experiments make accessible,” Elor said.
Specifically, the research team first considered the maximum cross-section of the mediator-mediated interaction with the protons and neutrons of an atomic nucleus to be consistent with astrological observations and certain particle-physics decays. The next step was to consider whether there was a model for dark matter that exhibited this interaction.
“And here we came up with the idea of the phase transition,” McGehee said. “We then calculated the amount of dark matter that exists in the universe and then simulated the phase transition using our calculations.”
There are a great many constraints to consider, such as a constant amount of dark matter.
“Here, we have to systematically consider and include very many scenarios, for example, asking the question whether it is really certain that our mediator does not suddenly lead to the formation of new dark matter, which of course must not be,” Elor said. “But in the end, we were convinced that our HYPER model works.”
The research is published in the journal Physical Review Letters.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]















